BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34916167)

  • 1. Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine.
    Casari I; Emmanouilidi A; Domenichini A; Falasca M
    Adv Biol Regul; 2022 Jan; 83():100857. PubMed ID: 34916167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.
    Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
    J Exp Clin Cancer Res; 2008 Aug; 27(1):30. PubMed ID: 18717994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target.
    Filippou PS; Karagiannis GS; Constantinidou A
    Oncogene; 2020 Mar; 39(10):2040-2054. PubMed ID: 31801970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer.
    Güngör C; Hofmann BT; Wolters-Eisfeld G; Bockhorn M
    Br J Pharmacol; 2014 Feb; 171(4):849-58. PubMed ID: 24024905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of midkine expression in pancreatic head carcinoma.
    Maeda S; Shinchi H; Kurahara H; Mataki Y; Noma H; Maemura K; Aridome K; Yokomine T; Natsugoe S; Aikou T; Takao S
    Br J Cancer; 2007 Aug; 97(3):405-11. PubMed ID: 17622248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midkine mRNA is overexpressed in pancreatic cancer.
    Ohhashi S; Ohuchida K; Mizumoto K; Egami T; Yu J; Cui L; Toma H; Takahata S; Nabae T; Tanaka M
    Dig Dis Sci; 2009 Apr; 54(4):811-5. PubMed ID: 18712601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Possible Interactions and Therapeutic Roles of Lithium Chloride and Midkine on Cancer Treatment.
    Bilir A; Aynacioglu AS; Tuna MY
    Crit Rev Oncog; 2019; 24(1):35-45. PubMed ID: 31679218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer.
    Hayward S; Gachehiladze M; Badr N; Andrijes R; Molostvov G; Paniushkina L; Sopikova B; Slobodová Z; Mgebrishvili G; Sharma N; Horimoto Y; Burg D; Robertson G; Hanby A; Hoar F; Rea D; Eckhardt BL; Ueno NT; Nazarenko I; Long HM; van Laere S; Shaaban AM; Berditchevski F
    J Pathol; 2020 May; 251(1):63-73. PubMed ID: 32129471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.
    Qiu J; Yang G; Feng M; Zheng S; Cao Z; You L; Zheng L; Zhang T; Zhao Y
    Mol Cancer; 2018 Jan; 17(1):2. PubMed ID: 29304816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
    Jones DR
    Br J Pharmacol; 2014 Jun; 171(12):2925-39. PubMed ID: 24460734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Profiling of Small Extracellular Vesicles Secreted by Human Pancreatic Cancer Cells Implicated in Cellular Transformation.
    Servage KA; Stefanius K; Gray HF; Orth K
    Sci Rep; 2020 May; 10(1):7713. PubMed ID: 32382024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
    Xu D; Wang Y; Zhou K; Wu J; Zhang Z; Zhang J; Yu Z; Liu L; Liu X; Li B; Zheng J
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of midkine in neuroblastoma tumourigenesis.
    Kishida S; Kadomatsu K
    Br J Pharmacol; 2014 Feb; 171(4):896-904. PubMed ID: 24116381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small extracellular vesicles as tumor biomarkers for glioblastoma.
    Mahmoudi K; Ezrin A; Hadjipanayis C
    Mol Aspects Med; 2015 Nov; 45():97-102. PubMed ID: 26118341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping and characterization of a retinoic acid-responsive enhancer of midkine, a novel heparin-binding growth/differentiation factor with neurotrophic activity.
    Matsubara S; Take M; Pedraza C; Muramatsu T
    J Biochem; 1994 Jun; 115(6):1088-96. PubMed ID: 7982887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.
    Nuzhat Z; Kinhal V; Sharma S; Rice GE; Joshi V; Salomon C
    Oncotarget; 2017 Mar; 8(10):17279-17291. PubMed ID: 27999198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress of midkine research on cancer].
    Kadomatsu K
    Nihon Rinsho; 2000 Jun; 58(6):1337-47. PubMed ID: 10879061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.
    Muramatsu T
    Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(4):410-25. PubMed ID: 20431264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midkine translocated to nucleoli and involved in carcinogenesis.
    Dai LC
    World J Gastroenterol; 2009 Jan; 15(4):412-6. PubMed ID: 19152444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of CD133-positive extracellular membrane vesicles in pancreatic cancer ascites and beyond.
    Fargeas CA; Karbanová J; Corbeil D
    Med Mol Morphol; 2020 Mar; 53(1):60-62. PubMed ID: 30953194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.